Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about ViaDerma, Inc.
ViaDerma, Inc. News
ViaDerma, Inc. Quantitative Score
About ViaDerma, Inc.
ViaDerma, Inc. operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company's lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries. It is also developing products in various fields of use, including topical antibiotics, toenail antifungal drugs, diabetic amputations, global acne, psoriasis, and eczema, as well as burns, anti-aging/wrinkle remover creams, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. The company was formerly known as Décor Products International, Inc. and changed its name to ViaDerma, Inc. in May 2014. ViaDerma, Inc. was incorporated in 2007 and is headquartered in Marina Del Rey, California.
ViaDerma, Inc. Earnings & Revenue
What’s This Company Really Worth? Find Out Instantly.
Warren Buffett’s go-to valuation method is Discounted Cash Flow (DCF). Our tool makes it effortless — no spreadsheets, just answers in a few clicks.
ViaDerma, Inc. Financials
Table Compare
Compare VDRM metrics with: | |||
|---|---|---|---|
Earnings & Growth | VDRM | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | VDRM | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | VDRM | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | VDRM | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
ViaDerma, Inc. Income
ViaDerma, Inc. Balance Sheet
ViaDerma, Inc. Cash Flow
ViaDerma, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Strong Sell |
| Return on Equity | Strong Buy |
| Return on Assets | Strong Sell |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Strong Sell |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Historical Market Cap
Shares Outstanding
ViaDerma, Inc. Executives
| Name | Role |
|---|---|
| Mr. Baotang Zhao | Chief Sales Officer |
| Mr. Zhang Xie | Corporate Secretary and Director |
| Mr. Qing Hua Lin | Chief Financial Officer and Director |
| Dr. Christopher A Otiko | Founder, Chief Executive Officer and President |
| Dr. Andrew Berman M.D., MPH | Medical Director and Member of Advisory Board |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Baotang Zhao | Chief Sales Officer | Male | 1978 | 28.77K |
| Mr. Zhang Xie | Corporate Secretary and Director | Male | 1979 | 9.18K |
| Mr. Qing Hua Lin | Chief Financial Officer and Director | Male | 1981 | 4.46K |
| Dr. Christopher A Otiko | Founder, Chief Executive Officer and President | -- | ||
| Dr. Andrew Berman M.D., MPH | Medical Director and Member of Advisory Board | -- |